Anesthesia for Pars Plana Vitrectomy (PPV) With Insulin Needle
Information source: King Khaled Eye Specialist Hospital
Information obtained from ClinicalTrials.gov on October 19, 2009
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Retinal Disorders
Intervention: needle (Device); needle (Device); Pars Plana Vitrectomy (Procedure)
Phase: N/A
Status: Recruiting
Sponsored by: King Khaled Eye Specialist Hospital Official(s) and/or principal investigator(s):
Waleed Riad, MD, Principal Investigator, Affiliation: KKESH
Overall contact:
Waleed Riad, MD,AB,SB, Phone: 0096614821234, Ext: 3215, Email: waleed_riad@yahoo.com
Summary
Periocular blockade with 12. 5 mm needle is as effective as block with 25 mm needle for
patients undergoing Pars Plana Vitrectomy.
Clinical Details
Official title: Anesthesia for PPV Using Insulin Needle
Study design: Treatment, Randomized, Single Blind (Investigator), Active Control, Parallel Assignment, Safety Study
Primary outcome: Efficacy of insulin needle.
Detailed description:
The author wants to see the effect of short needle in patients undergoing retinal surgery.
Eligibility
Minimum age: 40 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Adult patients undergoing pars plana vitrectomy under local anesthesia
Exclusion Criteria:
- Patients allergic to local anesthetic solutions
- With local sepsis
- Serious impairment of coagulation
- Orbital abnormalities
- Unable to cooperate in maintaining a relatively motionless supine position
- Who refused the anesthetic technique
Locations and Contacts
Waleed Riad, MD,AB,SB, Phone: 0096614821234, Ext: 3215, Email: waleed_riad@yahoo.com
King Khaled Eye Specialist hospital, Riyadh 11462, Saudi Arabia; Recruiting
Waleed Riad, Phone: 0096614821234, Ext: 3215, Email: waleed_riad@yahoo.com
Waleed Riad, MD, AB,SB, Principal Investigator
Additional Information
Starting date: August 2008
Ending date: December 2010
Last updated: June 15, 2009
|
